tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation
© 2013..
Saturated fatty acids (SFAs) induce hepatocyte cell death, wherein oxidative stress is mechanistically involved. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a master transcriptional regulator of cellular antioxidant defense enzymes. Therefore, Nrf2 activation is regarded as an effective strategy against oxidative stress-triggered cellular damage. In this study, tert-butylhydroquinone (tBHQ), a widely used Nrf2 activator, was initially employed to investigate the potential protective role of Nrf2 activation in SFA-induced hepatoxicity. As expected, SFA-induced hepatocyte cell death was prevented by tBHQ in both AML-12 mouse hepatocytes and HepG2 human hepatoma cells. However, the protective effect of tBHQ is Nrf2-independent, because the siRNA-mediated Nrf2 silencing did not abrogate tBHQ-conferred protection. Alternatively, our results revealed that autophagy activation was critically involved in the protective effect of tBHQ on lipotoxicity. tBHQ induced autophagy activation and autophagy inhibitors abolished tBHQ's protection. The induction of autophagy by tBHQ exposure was demonstrated by the increased accumulation of LC3 puncta, LC3-II conversion, and autophagic flux (LC3-II conversion in the presence of proteolysis inhibitors). Subsequent mechanistic investigation discovered that tBHQ exposure activated AMP-activated protein kinase (AMPK) and siRNA-mediated AMPK gene silencing abolished tBHQ-induced autophagy activation, indicating that AMPK is critically involved in tBHQ-triggered autophagy induction. Furthermore, our study provided evidence that tBHQ-induced autophagy activation is required for its Nrf2-activating property. Collectively, our data uncover a novel mechanism for tBHQ in protecting hepatocytes against SFA-induced lipotoxicity. tBHQ-triggered autophagy induction contributes not only to its hepatoprotective effect, but also to its Nrf2-activating property.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1841 |
|---|---|
| Enthalten in: |
Biochimica et biophysica acta - 1841(2014), 1 vom: 01. Jan., Seite 22-33 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Songtao [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 21.02.2014 Date Revised 10.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bbalip.2013.09.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM231060432 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM231060432 | ||
| 003 | DE-627 | ||
| 005 | 20231224085843.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbalip.2013.09.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0770.xml |
| 035 | |a (DE-627)NLM231060432 | ||
| 035 | |a (NLM)24055888 | ||
| 035 | |a (PII)S1388-1981(13)00195-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Li, Songtao |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.02.2014 | ||
| 500 | |a Date Revised 10.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2013. | ||
| 520 | |a Saturated fatty acids (SFAs) induce hepatocyte cell death, wherein oxidative stress is mechanistically involved. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a master transcriptional regulator of cellular antioxidant defense enzymes. Therefore, Nrf2 activation is regarded as an effective strategy against oxidative stress-triggered cellular damage. In this study, tert-butylhydroquinone (tBHQ), a widely used Nrf2 activator, was initially employed to investigate the potential protective role of Nrf2 activation in SFA-induced hepatoxicity. As expected, SFA-induced hepatocyte cell death was prevented by tBHQ in both AML-12 mouse hepatocytes and HepG2 human hepatoma cells. However, the protective effect of tBHQ is Nrf2-independent, because the siRNA-mediated Nrf2 silencing did not abrogate tBHQ-conferred protection. Alternatively, our results revealed that autophagy activation was critically involved in the protective effect of tBHQ on lipotoxicity. tBHQ induced autophagy activation and autophagy inhibitors abolished tBHQ's protection. The induction of autophagy by tBHQ exposure was demonstrated by the increased accumulation of LC3 puncta, LC3-II conversion, and autophagic flux (LC3-II conversion in the presence of proteolysis inhibitors). Subsequent mechanistic investigation discovered that tBHQ exposure activated AMP-activated protein kinase (AMPK) and siRNA-mediated AMPK gene silencing abolished tBHQ-induced autophagy activation, indicating that AMPK is critically involved in tBHQ-triggered autophagy induction. Furthermore, our study provided evidence that tBHQ-induced autophagy activation is required for its Nrf2-activating property. Collectively, our data uncover a novel mechanism for tBHQ in protecting hepatocytes against SFA-induced lipotoxicity. tBHQ-triggered autophagy induction contributes not only to its hepatoprotective effect, but also to its Nrf2-activating property | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a AMPK | |
| 650 | 4 | |a ARE | |
| 650 | 4 | |a Autophagy | |
| 650 | 4 | |a BSA | |
| 650 | 4 | |a Baf | |
| 650 | 4 | |a CQ | |
| 650 | 4 | |a CaMKK2 | |
| 650 | 4 | |a Calcium/calmodulin-dependent protein kinase kinase 2 | |
| 650 | 4 | |a EBSS | |
| 650 | 4 | |a ER | |
| 650 | 4 | |a ERK | |
| 650 | 4 | |a FFAs | |
| 650 | 4 | |a HO-1 | |
| 650 | 4 | |a JNK | |
| 650 | 4 | |a Keap1 | |
| 650 | 4 | |a Kelch-like ECH-associated protein 1 | |
| 650 | 4 | |a LC3 | |
| 650 | 4 | |a LKB1 | |
| 650 | 4 | |a Lipotoxicity | |
| 650 | 4 | |a NAFLD | |
| 650 | 4 | |a Nrf2 | |
| 650 | 4 | |a PP2A | |
| 650 | 4 | |a ROS | |
| 650 | 4 | |a SFAs | |
| 650 | 4 | |a adenosine monophosphate-activated protein kinase | |
| 650 | 4 | |a amino acid and serum depletion medium | |
| 650 | 4 | |a antioxidant response element | |
| 650 | 4 | |a bafilomycin A1 | |
| 650 | 4 | |a bovine serum albumin | |
| 650 | 4 | |a c-Jun N-terminal kinase | |
| 650 | 4 | |a chloroquine | |
| 650 | 4 | |a endoplasmic reticulum | |
| 650 | 4 | |a extracellular signal-regulated kinases | |
| 650 | 4 | |a free fatty acids | |
| 650 | 4 | |a heme oxygenase 1 | |
| 650 | 4 | |a liver kinase B1 | |
| 650 | 4 | |a mTOR | |
| 650 | 4 | |a mammalian target of rapamycin | |
| 650 | 4 | |a microtubule associated protein 1 (MAP1) light chain 3 | |
| 650 | 4 | |a non-alcohol fatty liver diseases | |
| 650 | 4 | |a nuclear factor (erythroid-derived 2)-like 2 | |
| 650 | 4 | |a protein phosphatase 2A | |
| 650 | 4 | |a reactive oxygen species | |
| 650 | 4 | |a saturated fatty acids | |
| 650 | 4 | |a tBHQ | |
| 650 | 4 | |a tert-Butylhydroquinone | |
| 650 | 4 | |a tert-butylhydroquinone | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 650 | 7 | |a Fatty Acids |2 NLM | |
| 650 | 7 | |a Hydroquinones |2 NLM | |
| 650 | 7 | |a LC3 protein, rat |2 NLM | |
| 650 | 7 | |a MAP1LC3A protein, human |2 NLM | |
| 650 | 7 | |a Microtubule-Associated Proteins |2 NLM | |
| 650 | 7 | |a NF-E2-Related Factor 2 |2 NLM | |
| 650 | 7 | |a NFE2L2 protein, human |2 NLM | |
| 650 | 7 | |a Nfe2l2 protein, rat |2 NLM | |
| 650 | 7 | |a 2-tert-butylhydroquinone |2 NLM | |
| 650 | 7 | |a C12674942B |2 NLM | |
| 650 | 7 | |a AMP-Activated Protein Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.31 |2 NLM | |
| 700 | 1 | |a Li, Jiaxin |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Chen |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ximei |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Shan |e verfasserin |4 aut | |
| 700 | 1 | |a Cho, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Changhao |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Zhenyuan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biochimica et biophysica acta |d 1948 |g 1841(2014), 1 vom: 01. Jan., Seite 22-33 |w (DE-627)NLM000000698 |x 0006-3002 |7 nnns |
| 773 | 1 | 8 | |g volume:1841 |g year:2014 |g number:1 |g day:01 |g month:01 |g pages:22-33 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbalip.2013.09.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 1841 |j 2014 |e 1 |b 01 |c 01 |h 22-33 | ||